Xtalks

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

In this week’s episode of the Xtalks Life Science Podcast, host Vera Kovacevic, Editor-in-Chief at Xtalks, spoke with Hyung Heon Kim, CEO of MetaVia, a clinical-stage biotechnology company developing treatments for cardiometabolic diseases. Mr. Kim discusses the evolving cardiometabolic disease landscape, including the connections between obesity, diabetes, liver disease and cardiovascular risk.

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

This privacy policy describes the privacy practices for www.Xtalks.com (hereafter referred to as “the Site”). Citizens of the UK and EU should refer to EU and UK – PRIVACY POLICY – HONEYCOMB WORLDWIDE INC. All users of the Site should read this privacy policy in conjunction with the Site’s TERMS OF USE. The Site is owned and operated by Honeycomb Worldwide Inc. (hereafter referred to as “Honeycomb”, “we”, “us” or “our”).

In a year marked by shifts in regulatory and market dynamics, innovation in biopharma continues to gain momentum. According to Fast Company, the top pharmaceutical companies of 2026 are redefining treatment paradigms, from HIV prevention and gene therapy to AI-driven drug discovery and next-generation manufacturing. Below is a closer look at the 10 most innovative pharma companies of 2026. Select all that apply.